Skip to content

US · RNTX

Rein Therapeutics Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Austin, TX 78758
Website
reintx.com

Price · as of 2026-09-03

$0.84

Market cap 19.97M

Price history

Weekly OHLC price history for RNTX, USD per share
WeekOpenHighLowCloseVolume
Dec 16, 2024 – Dec 20, 2024$2.23$2.35$1.70$1.750
Dec 23, 2024 – Dec 27, 2024$1.77$2.30$1.69$2.230
Dec 30, 2024 – Jan 3, 2025$2.23$2.40$2.01$2.280
Jan 6, 2025 – Jan 10, 2025$2.25$2.29$1.93$2.110
Jan 13, 2025 – Jan 17, 2025$2.10$2.10$1.84$2.000
Jan 20, 2025 – Jan 24, 2025$2.01$2.65$1.89$2.200
Jan 27, 2025 – Jan 31, 2025$2.13$3.50$1.97$1.970
Feb 3, 2025 – Feb 7, 2025$1.93$2.41$1.88$2.050
Feb 10, 2025 – Feb 14, 2025$2.16$2.50$2.08$2.440
Feb 17, 2025 – Feb 21, 2025$2.37$2.96$2.28$2.700
Feb 24, 2025 – Feb 28, 2025$2.72$2.78$2.04$2.090
Mar 3, 2025 – Mar 7, 2025$2.08$2.27$1.90$1.990
Mar 10, 2025 – Mar 14, 2025$1.99$2.10$1.66$2.000
Mar 17, 2025 – Mar 21, 2025$1.95$2.07$1.87$1.910
Mar 24, 2025 – Mar 28, 2025$1.95$1.97$1.63$1.700
Mar 31, 2025 – Apr 4, 2025$1.75$1.98$1.50$1.700
Apr 7, 2025 – Apr 11, 2025$1.55$1.81$1.35$1.710
Apr 14, 2025 – Apr 17, 2025$1.67$1.75$1.57$1.700
Apr 21, 2025 – Apr 25, 2025$1.65$1.92$1.56$1.910
Apr 28, 2025 – May 2, 2025$1.91$1.91$1.51$1.820
May 5, 2025 – May 9, 2025$1.74$1.81$1.60$1.760
May 12, 2025 – May 16, 2025$1.78$2.40$1.70$2.210
May 19, 2025 – May 23, 2025$2.15$2.22$1.87$2.050
May 26, 2025 – May 30, 2025$2.09$2.21$1.84$1.950
Jun 2, 2025 – Jun 6, 2025$1.96$2.09$1.85$2.000
Jun 9, 2025 – Jun 13, 2025$2.01$2.02$1.69$1.880
Jun 16, 2025 – Jun 20, 2025$1.94$1.94$1.44$1.540
Jun 23, 2025 – Jun 27, 2025$1.65$1.66$1.36$1.470
Jun 30, 2025 – Jul 3, 2025$1.47$1.55$1.33$1.510
Jul 7, 2025 – Jul 11, 2025$1.51$1.60$1.42$1.440
Jul 14, 2025 – Jul 18, 2025$1.39$1.59$1.37$1.420
Jul 21, 2025 – Jul 25, 2025$1.40$1.58$1.34$1.460
Jul 28, 2025 – Aug 1, 2025$1.46$1.46$1.05$1.110
Aug 4, 2025 – Aug 8, 2025$1.10$1.24$1.04$1.110
Aug 11, 2025 – Aug 15, 2025$1.09$1.23$1.06$1.190
Aug 18, 2025 – Aug 22, 2025$1.19$1.30$1.06$1.270
Aug 25, 2025 – Aug 29, 2025$1.23$1.40$1.06$1.390
Sep 1, 2025 – Sep 5, 2025$1.34$1.48$1.23$1.330
Sep 8, 2025 – Sep 12, 2025$1.34$1.43$1.07$1.190
Sep 15, 2025 – Sep 19, 2025$1.21$1.34$1.08$1.210
Sep 22, 2025 – Sep 26, 2025$1.21$1.33$1.12$1.180
Sep 29, 2025 – Oct 3, 2025$1.18$1.21$1.13$1.190
Oct 6, 2025 – Oct 10, 2025$1.18$1.57$1.18$1.300
Oct 13, 2025 – Oct 17, 2025$1.30$1.36$1.18$1.220
Oct 20, 2025 – Oct 24, 2025$1.25$1.46$1.22$1.440
Oct 27, 2025 – Oct 31, 2025$1.49$1.75$1.30$1.570
Nov 3, 2025 – Nov 7, 2025$1.69$2.18$1.35$1.600
Nov 10, 2025 – Nov 14, 2025$1.57$1.65$1.15$1.250
Nov 17, 2025 – Nov 21, 2025$1.22$1.52$1.15$1.480
Nov 24, 2025 – Nov 28, 2025$1.41$1.58$1.41$1.570
Dec 1, 2025 – Dec 5, 2025$1.57$1.57$1.34$1.360
Dec 8, 2025 – Dec 12, 2025$1.35$1.56$1.35$1.550
Dec 15, 2025 – Dec 19, 2025$1.55$1.55$1.28$1.420
Dec 22, 2025 – Dec 26, 2025$1.42$1.47$1.20$1.240
Dec 29, 2025 – Jan 2, 2026$1.22$1.26$1.02$1.250
Jan 5, 2026 – Jan 9, 2026$1.25$1.30$1.13$1.170
Jan 12, 2026 – Jan 16, 2026$1.15$1.25$1.08$1.210
Jan 19, 2026 – Jan 23, 2026$1.12$1.44$1.12$1.370
Jan 26, 2026 – Jan 30, 2026$1.36$1.63$1.26$1.300
Feb 2, 2026 – Feb 6, 2026$1.28$1.42$1.11$1.140
Feb 9, 2026 – Feb 13, 2026$1.16$1.22$1.09$1.120
Feb 16, 2026 – Feb 20, 2026$1.11$1.28$1.08$1.210
Feb 23, 2026 – Feb 27, 2026$1.23$1.34$1.09$1.140
Mar 2, 2026 – Mar 6, 2026$1.16$1.27$1.15$1.200
Mar 9, 2026 – Mar 13, 2026$1.21$1.39$1.15$1.300
Mar 16, 2026 – Mar 20, 2026$1.30$1.47$1.16$1.240
Mar 23, 2026 – Mar 27, 2026$1.20$1.37$1.12$1.250
Mar 30, 2026 – Apr 2, 2026$1.28$1.33$1.11$1.210
Apr 6, 2026 – Apr 10, 2026$1.24$1.70$1.24$1.490
Apr 13, 2026 – Apr 17, 2026$1.47$1.85$1.42$1.760
Apr 20, 2026 – Apr 24, 2026$1.73$2.10$1.63$1.660
Apr 27, 2026 – May 1, 2026$1.64$1.68$1.00$1.030
May 4, 2026 – May 8, 2026$1.06$1.24$1.00$1.220
May 11, 2026 – May 15, 2026$1.22$1.23$1.01$1.050
May 18, 2026 – May 22, 2026$1.10$1.14$0.95$1.030
May 25, 2026 – May 29, 2026$1.05$1.17$1.01$1.110
Jun 1, 2026 – Jun 5, 2026$1.08$1.12$0.94$0.940
Jun 8, 2026 – Jun 12, 2026$0.96$1.04$0.89$0.960
Jun 15, 2026 – Jun 18, 2026$0.95$1.01$0.86$0.920
Jun 22, 2026 – Jun 26, 2026$0.92$1.02$0.88$0.970
Jun 29, 2026 – Jul 2, 2026$0.97$1.05$0.95$0.990
Jul 6, 2026 – Jul 10, 2026$0.98$1.05$0.94$0.980
Jul 13, 2026 – Jul 17, 2026$0.96$1.00$0.85$0.860
Jul 20, 2026 – Jul 24, 2026$0.89$0.93$0.76$0.790
Jul 27, 2026 – Jul 31, 2026$0.80$0.83$0.73$0.740
Aug 3, 2026 – Aug 7, 2026$0.74$0.82$0.69$0.820
Aug 10, 2026 – Aug 14, 2026$0.83$0.86$0.76$0.810
Aug 17, 2026 – Aug 21, 2026$0.82$0.88$0.77$0.820
Aug 24, 2026 – Aug 28, 2026$0.82$0.82$0.76$0.760
Aug 31, 2026 – Sep 3, 2026$0.77$0.87$0.73$0.840

Valuation

MetricValueUpside
IC Value
P/E-0.66
P/B1.96
P/S
EV/EBITDA-0.59
PEG
P/TBV-11.36

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for RNTX, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020$32.60
2021$8.34
2022$1.30
2023$5.83
2024$1.99
2025$1.30

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Rein Therapeutics Inc.

        Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky, and its main corporate offices are situated in Austin, Texas.

        CEO
        James Brian Windsor
        Employees
        10
        Beta
        1.35

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for RNTX: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        RNTXRein Therapeutics Inc.$0.8219.97M-0.661.96-0.59-11.360.00%0.00%0.00%-139.87%-78.30%-106.79%0.000.700.520.06-44.16%-13.14%-58.53%-3.13-70.11%0.00%0.00%0.00%-1.36-1.54-23.60
        BCABBioAtla, Inc.$3.334.19M$45.06+1,255%-0.16-0.274.85-0.15-0.27-2053.65%-2965.25%-2980.35%543.76%166.93%-179.95%-0.170.370.320.02-29.86%-81.82%-32.99%-496.61%-2.20135.69%0.00%0.00%0.00%-0.15-0.184.39-70.34
        BEATHeartBeam, Inc.$0.5017.18M-2.1817.61-1.9817.610.00%0.00%0.00%-987.32%1691.12%-460.91%0.001.451.350.21-15.07%-0.57%-31.82%-4.321167.04%0.00%0.00%4.37%-1.96-2.84-21.67
        CELUCelularity Inc.$0.7321.25M$6.20+744%-0.34-0.821.18-0.85-0.95-0.5976.04%-230.92%-345.76%627.65%-166.60%-76.43%-1.07-9.080.150.13-0.4535.75%-51.03%101.98%-42.44%-0.16-36.02%18.89%-6.40%125.75%-1.08-4.982.48-15.21
        QNTMQuantum BioPharma Ltd.$2.9018.56M-0.311.18-0.153.390.00%0.00%0.00%-284.63%-396.27%-185.25%0.27-24.741.071.060.00-35.07%21.88%-102.85%-1.39-217.04%0.00%0.00%0.00%-0.25-0.46-28.55
        TPSTTempest Therapeutics, Inc…$0.914.06M-0.361.41-0.38-0.111.410.00%0.00%0.00%-203.63%-469.32%-89.91%1.22-128.382.502.33-0.02322.00%-19.85%-285.98%-8.09-473.64%0.00%0.00%0.00%-0.37-0.37-23.58
        YI111, Inc.$3.7032.32M$17.12+363%-17.13-0.550.03-4.56-0.555.76%-0.08%-0.14%3.35%1.03%-0.90%-0.31-0.291.090.48-189.82-1.33%-15.19%-53.72%29.73%0.06-11.79%0.00%0.00%35.88%0.82-0.070.003.23

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.84) − 1 = — (IC, example).